BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8045536)

  • 1. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders.
    Wilens TE; Biederman J; Spencer TJ; Frances RJ
    Hosp Community Psychiatry; 1994 May; 45(5):421-3, 435. PubMed ID: 8045536
    [No Abstract]   [Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are attention-deficit hyperactivity disorder and the psychoactive substance use disorders really related?
    Wilens TE; Spencer TJ; Biederman J
    Harv Rev Psychiatry; 1995; 3(3):160-2. PubMed ID: 9384944
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.
    Wilens TE; Biederman J; Mick E; Faraone SV; Spencer T
    J Nerv Ment Dis; 1997 Aug; 185(8):475-82. PubMed ID: 9284860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children.
    Milberger S; Biederman J; Faraone SV; Wilens T; Chu MP
    Am J Addict; 1997; 6(4):318-29. PubMed ID: 9398930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial transmission of ADHD and psychoactive substance use disorders.
    Adler LA
    Am J Psychiatry; 2008 Jan; 165(1):11-2. PubMed ID: 18178750
    [No Abstract]   [Full Text] [Related]  

  • 9. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity in children and adolescent psychiatry.
    Burgić-Radmanović M; Burgić S
    Psychiatr Danub; 2010 Jun; 22(2):298-300. PubMed ID: 20562768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attention deficit hyperactivity disorder (ADHD) and addiction].
    Hässler F; Reis O
    MMW Fortschr Med; 2010 May; 152(18):46-8. PubMed ID: 20514764
    [No Abstract]   [Full Text] [Related]  

  • 12. Childhood trauma exposure in substance use disorder patients with and without ADHD.
    Konstenius M; Leifman A; van Emmerik-van Oortmerssen K; van de Glind G; Franck J; Moggi F; Ramos-Quiroga JA; Levin FR; Carpentier PJ; Skutle A; Bu ET; Kaye S; Demetrovics Z; Barta C; Auriecomb M; Fatséas M; Johnson B; Faraone SV; Allsop S; Carruthers S; Schoevers RA; Verspreet S; Dom G; Koeter MW; van den Brink W
    Addict Behav; 2017 Feb; 65():118-124. PubMed ID: 27816036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity.
    Biederman J; Wilens T; Mick E; Milberger S; Spencer TJ; Faraone SV
    Am J Psychiatry; 1995 Nov; 152(11):1652-8. PubMed ID: 7485630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders.
    Biederman J; Petty CR; Wilens TE; Fraire MG; Purcell CA; Mick E; Monuteaux MC; Faraone SV
    Am J Psychiatry; 2008 Jan; 165(1):107-15. PubMed ID: 18006872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of symptoms of attention-deficit hyperactivity disorder in adults with substance use disorders.
    Milin R; Loh E; Chow J; Wilson A
    Psychiatr Serv; 1997 Nov; 48(11):1378-80, 1395. PubMed ID: 9355162
    [No Abstract]   [Full Text] [Related]  

  • 16. Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults.
    Wilens TE; Prince JB; Biederman J; Spencer TJ; Frances RJ
    Psychiatr Serv; 1995 Aug; 46(8):761-3, 765. PubMed ID: 7583473
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of ADHD in adult substance abusers.
    Moura HF; Faller S; Benzano D; Szobot C; von Diemen L; Stolf AR; Souza-Formigoni ML; Cruz MS; Brasiliano S; Pechansky F; Kessler FH
    J Addict Dis; 2013; 32(3):252-62. PubMed ID: 24074191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses.
    Charach A; Yeung E; Climans T; Lillie E
    J Am Acad Child Adolesc Psychiatry; 2011 Jan; 50(1):9-21. PubMed ID: 21156266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotherapy of adults with comorbid attention-deficit/hyperactivity disorder and psychoactive substance use disorder.
    Aviram RB; Rhum M; Levin FR
    J Psychother Pract Res; 2001; 10(3):179-86. PubMed ID: 11402081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders.
    Milberger S; Faraone SV; Biederman J; Chu MP; Wilens T
    Arch Pediatr Adolesc Med; 1998 Oct; 152(10):945-51. PubMed ID: 9790603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.